Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer (Q41902053)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 June 2013

Language	Label	Description	Also known as
English	Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer	scientific article published on 20 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Li Pang

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Jing Wang

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Yanwen Jiang

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Liangan Chen

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

publication date

20 June 2013

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Experimental and Therapeutic Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

355-360

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Cancer cells in transit: the vascular interactions of tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

5 June 2018

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, an

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Increased serum CA-125 levels in patients with lung cancer post thoracotomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786728

18 August 2018

Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers in the lung cancer diagnosis: a clinical perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/ETM.2013.1171

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41902053&oldid=1929572074"